Therapeutic Goods Act 1989
I, Larry Kelly, Coordinator, Monitoring & Compliance Group, Therapeutic Goods Administration and delegate ofthe Secretary to the Department of Health and Ageing for the purposes of section 42 DK (I) of the Therapeutic Goods Act, give notice that the restricted representations described in paragraph (a) below, being representations that are necessary for the appropriate use of the therapeutic goods described in paragraph (b) below, may be included either on the label of the package of those goods or in information included in the package in which those goods are contained:
- representations to the effect that the goods described in paragraph (b) below may be used "For the treatment of patients with known cardiovascular or cerebrovascular disease, as an antiplatelet agent for prophylaxis against acute myocardial infarction, unstable angina, transient ischaemic attack and cerebrovascular accident (stroke)" and "Trust Thrombix inhibits blood clotting and reduces the risk of heart attack and stroke in patients with known cardiovascular or cerebrovascular disease".
- TRUST THROMBIX LOW DOSE ASPIRIN lOOmg enteric coated tablet blister pack
- supplied as an over-the-counter drug by Pharmacor Limited.
Dated this 18th day of August 2010
Larry Kelly
Delegate of the Secretary to the Department of Health and Ageing